Israeli Pulmonology Association Assures No Shortage After Ventolin Inhaler Marketing Halt
The recent announcement of the discontinuation of Ventolin inhaler marketing in Israel has raised concerns among asthma and COPD patients. However, the Israeli Pulmonology Association urges calm, emphasizing that there is no shortage of treatment options and that effective alternatives are available on the market. Dr. Inbal Shafran, a senior physician at the Beilinson Lung Institute and a member of the association's board, explained that several medications contain the same active ingredient, salbutamol, and other fast-acting inhalers like Atrovent are also available. Therefore, patients currently using Ventolin will not be left without therapeutic options.
The association also views this change as an opportunity to update treatments according to the latest medical guidelines. Dr. Shafran stressed that Ventolin is not recommended as a sole inhaler treatment for asthma. Current guidelines discourage using bronchodilator-only inhalers without inhaled corticosteroids, as this approach may increase the risk of severe asthma attacks and disease exacerbations. Treatment strategies have evolved significantly, with many cases now favoring combination inhalers that include both corticosteroids and fast-acting bronchodilators, which can be used for maintenance and symptom relief based on physician advice.
Experts further warn that frequent use of Ventolin or reliance solely on a "rescue inhaler" signals poorly controlled asthma or COPD. Patients experiencing this should consult their family doctor or pulmonologist for reassessment and treatment adjustment. The association highlights that asthma and COPD treatments have advanced considerably, offering better disease control, reduced exacerbation risks, and improved quality of life. They strongly advise patients not to stop their medication independently due to the Ventolin marketing halt but to seek medical guidance to tailor alternative treatments and update their care plans accordingly.
